Alcor Scientific Presents Latest Innovation in High Volume ESR Testing
By LabMedica International staff writers Posted on 12 Nov 2024 |

ALCOR Scientific (Smithfield, RI, USA) is attending MEDICA 2024 in Düsseldorf, the world’s largest event for the medical sector, where the company is presenting its latest innovations in high-volume erythrocyte sedimentation rate (ESR) testing.
At this year’s MEDICA, ALCOR is presenting its new iSED PRO fully automated ESR analyzer with a bi-directional interface that is designed to streamline ESR testing for busy, high-volume reference laboratories. The iSED PRO analyzer is rack-compatible and fully automated, significantly reducing the hands-on time and turnaround time required to produce an ESR result. Results are generated in seconds using a small blood sample, allowing for multiple hematology tests to be run off the same primary tube sample. iSED PRO is designed for maximum throughput while offering the flexibility to accommodate each laboratory’s unique workflow.
Among its versatile family of ESR solutions, ALCOR is also showcasing the iSED and iSED ELITE ESR analyzers which are typically suited for medium-high volume labs. These analyzers significantly improve ESR testing efficiency by generating results in seconds with the most automated ESR testing process. These automated, compact benchtop systems enable moderately complex urgent care labs to easily generate truly STAT ESR results in seconds with a small sample volume. Also on display at the trade show is the miniiSED ESR analyzer that helps urgent care centers to bring more testing services in-house. The miniiSED ESR is a compact benchtop analyzer that can generate truly STAT ESR results in seconds from a small sample volume. This allows practices to have results available during a patient visit which can positively impact patient care as well as patient satisfaction, particularly in a rheumatology practice. Operationally, miniiSED can enhance efficiency helping reduce send-out tests and allowing for more tests to be performed with one primary tube sample (compared to other ESR methods that require larger sample volumes).
Related Links:
ALCOR Scientific
Latest Medica 2024 News
- EDAN Instruments Highlights Range of Lab Analyzers, ECG Devices and Ultrasound Systems
- BioVendor Group Introduces Groundbreaking Immunological Biomarker
- Getein Biotech Showcases Latest POCT Analyzers
- Fapon Highlights Innovative IVD Total Solutions and Localization Services
- Wondfo Presents Advanced Solutions in CLIA Testing and Blood Gas Analysis
- Globe Scientific Exhibits Cutting-Edge Solutions for Meeting Laboratory Needs
- LGC Clinical Diagnostics Presents Seraseq and ACCURUN Range of Diagnostic Solutions
- Oruba Showcases Innovative Self-Operating Uroflowmeter
- Awareness Technology Showcases Range of Cutting-Edge Analyzers
- Sentinel Diagnostics Presents Latest Breakthroughs in Diagnostics
- CerTest Showcases Latest Innovations in Diagnosis of Infectious Diseases
- Vircell Presents Latest Offerings and Products in Diagnostic Testing
- Tianlong Demonstrates Latest Biochemistry, Immunology, POCT and Molecular Diagnostic Products
- EKF Presents Cutting-Edge Point-Of-Care Diagnostic Solutions
- Vedalab Exhibits Rapid Diagnostic Tests
- Meridian Showcases Innovative Solutions for Molecular Diagnostics and Immunoassays
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more
New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
"Liquid biopsy" technology, which relies on blood tests for early cancer detection and monitoring cancer burden in patients, has the potential to transform cancer care. However, detecting the mutational... Read more
"Metal Detector" Algorithm Hunts Down Vulnerable Tumors
Scientists have developed an algorithm capable of functioning as a "metal detector" to identify vulnerable tumors, marking a significant advancement in personalized cancer treatment. This breakthrough... Read more
Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
Pancreatic cancer is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Consequently, only 15% of pancreatic cancers are diagnosed early enough to allow for... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more